BR112014030232A2 - cerclagem de pessário que contenham progesterona de longa, sustentada e contínua liberação útil para prevenção de parto prematuro - Google Patents

cerclagem de pessário que contenham progesterona de longa, sustentada e contínua liberação útil para prevenção de parto prematuro

Info

Publication number
BR112014030232A2
BR112014030232A2 BR112014030232A BR112014030232A BR112014030232A2 BR 112014030232 A2 BR112014030232 A2 BR 112014030232A2 BR 112014030232 A BR112014030232 A BR 112014030232A BR 112014030232 A BR112014030232 A BR 112014030232A BR 112014030232 A2 BR112014030232 A2 BR 112014030232A2
Authority
BR
Brazil
Prior art keywords
pessary
cerclage
sustained
progesterone
useful
Prior art date
Application number
BR112014030232A
Other languages
English (en)
Inventor
Arzobindo Campos Pérez Germán
Chen Shu-Chen
Original Assignee
Laboratorios Andromaco S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Andromaco S A filed Critical Laboratorios Andromaco S A
Publication of BR112014030232A2 publication Critical patent/BR112014030232A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Abstract

resumo cerclagem de pessário que contenham progesterona de longa, sustentada e contínua liberação útil para prevenção de parto prematuro cerclagem de pessário contendo progesterona homogeneamente distribuído no corpo do pessário proporcionando uma prolongada, sustentada e libertação contínua durante um período de pelo menos 6 meses, em que o pessário consiste de dimetilsiloxano com elastômero rtv (vulcanização à temperatura ambiente) de mecanismo, a quantidade de progesterona é a partir de 20% a 30% p/p, em relação ao peso de pessário e as razões dos polímeros que formam a matriz é de 6:1 a 14:1. a cerclagem de pessário é útil para a prevenção do parto prematuro. o progesterona difunde através do polímero continuamente, sem alterar a forma e integridade do pessário, uma vez que o elastômero formando a matriz polimérica é aqui utilizado não é biodegradável. isto garante que a forma de pessário permanece intacta até ao final do tratamento.
BR112014030232A 2014-06-28 2014-06-28 cerclagem de pessário que contenham progesterona de longa, sustentada e contínua liberação útil para prevenção de parto prematuro BR112014030232A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2014/062691 WO2015198104A1 (es) 2014-06-28 2014-06-28 Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro

Publications (1)

Publication Number Publication Date
BR112014030232A2 true BR112014030232A2 (pt) 2017-06-27

Family

ID=54937437

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014030232A BR112014030232A2 (pt) 2014-06-28 2014-06-28 cerclagem de pessário que contenham progesterona de longa, sustentada e contínua liberação útil para prevenção de parto prematuro

Country Status (20)

Country Link
US (1) US9820994B2 (pt)
EP (1) EP2982352B1 (pt)
JP (1) JP6529583B2 (pt)
KR (1) KR20170021929A (pt)
CN (1) CN105392454B (pt)
AR (2) AR098604A1 (pt)
BR (1) BR112014030232A2 (pt)
CA (1) CA2873222A1 (pt)
CR (1) CR20160604A (pt)
CY (1) CY1121245T1 (pt)
DK (1) DK2982352T3 (pt)
ES (1) ES2699003T3 (pt)
HR (1) HRP20181794T1 (pt)
HU (1) HUE040176T2 (pt)
LT (1) LT2982352T (pt)
MX (1) MX368212B (pt)
PL (1) PL2982352T3 (pt)
PT (1) PT2982352T (pt)
SI (1) SI2982352T1 (pt)
WO (1) WO2015198104A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102110132B1 (ko) * 2017-10-27 2020-05-13 고려대학교산학협력단 자궁경부 무력증에서 조산을 방지하기 위한 자궁경부 밴드 구조체
US11497647B2 (en) 2018-04-24 2022-11-15 Emory University Anatomical support systems, devices, and related methods
US11311409B2 (en) 2018-05-19 2022-04-26 Ashley Camille CRAFTON Hannah cervical cup
US11872395B2 (en) 2019-06-18 2024-01-16 Obstetric Solutions, Llc Pessary device and methods for preventing premature births
EP4069248A4 (en) * 2019-12-06 2024-01-03 Prathima Chowdary SUSTAINED RELEASE VAGINAL RING PESSARY FOR TREATMENT OF ATROPHY, CYSTITIS AND UTEROVAGINAL PROLAPSUS
KR102571791B1 (ko) * 2021-03-22 2023-08-28 가톨릭대학교 산학협력단 산모 맞춤형 조산 예방용 페서리 및 이의 제조방법

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US415991A (en) 1889-11-26 zipernowsky
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
EG11114A (en) * 1973-12-06 1977-01-31 Schering Ag Dispositif contraceptif intra-uterin
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JP2590358B2 (ja) * 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
DE19606355A1 (de) * 1996-02-12 1997-08-14 Schering Ag Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung
FR2745180B1 (fr) * 1996-02-23 1998-05-07 Dow Corning Sa Procede de fabrication de dispositifs a liberation controlee
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
CN1184957C (zh) * 1997-05-07 2005-01-19 盖伦(化学制品)有限公司 用于给药睾酮和睾酮前体的阴道内给药装置
EP1030629A4 (en) 1997-11-03 2001-09-05 Deschutes Medical Products Inc PESSAR WITH A CARTRIDGE CONTAINING DRUGS
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20050197651A1 (en) * 2001-04-25 2005-09-08 Chen Hai L. Vaginal ring preparation and its application
US20040089308A1 (en) 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
ATE461681T1 (de) 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
PT1768625E (pt) 2004-07-09 2011-04-18 Hra Pharma Lab Composições de libertação sustida contendo moduladores do receptor da progesterona
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
MX337634B (es) 2008-02-04 2016-03-14 Teva Womens Health Inc Anillos intravaginales monoliticos que comprenden progesterona y metodos de manufactura y uso de los mismos.
FI20085277A0 (fi) * 2008-04-02 2008-04-02 Bayer Schering Pharma Oy Kohdunsisäinen järjestelmä
EP2456421B1 (en) 2009-07-21 2017-04-05 The Population Council, Inc. Multi-layered gradient vaginal ring
US20110236462A1 (en) * 2010-03-28 2011-09-29 Shaked Ze Ev Intravaginal drug delivery device
US8580294B2 (en) * 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US9937335B2 (en) * 2011-06-06 2018-04-10 Oak Crest Institute Of Science Drug delivery device employing wicking release window
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
DE102012009057A1 (de) 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente

Also Published As

Publication number Publication date
CR20160604A (es) 2017-03-10
JP2017524030A (ja) 2017-08-24
SI2982352T1 (sl) 2018-12-31
CY1121245T1 (el) 2020-05-29
DK2982352T3 (en) 2018-11-26
LT2982352T (lt) 2018-11-12
WO2015198104A1 (es) 2015-12-30
US9820994B2 (en) 2017-11-21
US20160250229A1 (en) 2016-09-01
PL2982352T3 (pl) 2019-01-31
EP2982352A4 (en) 2017-06-14
HUE040176T2 (hu) 2019-02-28
EP2982352B1 (en) 2018-10-03
MX368212B (es) 2019-09-24
AR098604A1 (es) 2016-06-01
CA2873222A1 (en) 2015-12-28
EP2982352A1 (en) 2016-02-10
ES2699003T3 (es) 2019-02-06
CN105392454B (zh) 2018-05-08
HRP20181794T1 (hr) 2018-12-28
PT2982352T (pt) 2018-11-29
KR20170021929A (ko) 2017-03-02
JP6529583B2 (ja) 2019-06-12
CN105392454A (zh) 2016-03-09
MX2014014769A (es) 2016-03-30
AR122434A2 (es) 2022-09-14

Similar Documents

Publication Publication Date Title
BR112014030232A2 (pt) cerclagem de pessário que contenham progesterona de longa, sustentada e contínua liberação útil para prevenção de parto prematuro
BR112018014553A2 (pt) gaiola de confinamento de enxerto de osso helicoidal
BR112019007798A2 (pt) veículo de liberação oral
BR112016008409A2 (pt) Uso de um agente inibidor de masp-2 que inibe a ativação de complemento dependente de masp-2
BR112017017629A2 (pt) processo para produção de uma composição.
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
BR112017009145A2 (pt) ?sistema de molde de tela de cisalhamento compreendendo placas de moldagem variáveis?
BR112019008230A2 (pt) compostos de polímero de liberação de sulfeto de hidrogênio
BR112017008282B8 (pt) Copolímero de polietileno catalisado com metaloceno reticulado e cano
BR112016007462A2 (pt) fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite
BR112017006406A2 (pt) composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico
BR112013004043A2 (pt) polímeros aromáticos vinílicos expansíveis
BR112018007611A2 (pt) ácidos nucleicos p-etóxi para formulação lipossômica
BR112019007446A2 (pt) agente desodorante compreendendo neodecanoato de zinco
BR112015019344A2 (pt) seletor de conjunto de peso e mecanismo de travamento
BR112017007517A2 (pt) sistema acelerador para um látex de polímero de isopreno, composição, e, bens imersos.
BR112017014361A2 (pt) métodos para aperfeiçoamento de terapia celular
CO2017005625A2 (es) Panel de construcción que posee una fuerza de fijación mejorada
BR112015015684A2 (pt) tubo flexível
BR112018068817A2 (pt) beta-caseínas e função cognitiva
BR112015032665A2 (pt) molde ortopédico e ataduras com meio de endurecimento encapsulado e método
BR112016018794A2 (pt) Filmes microcapilares
BR112016025265A2 (pt) corpo endurecido com gipsita, painel de gipsita, método para a fabricação de um corpo endurecido com gipsita, e método para a fabricação de uma placa de gipsita
HRP20180967T1 (hr) Pripravak za liječenje hipokalcijemije kod preživača
BR112019024854A2 (pt) composição de poliolefina com odor e embaçamento reduzidos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements